14-day Premium Trial Subscription Sign Up For FreeGet Free

Bio-Path Holdings Stock Forecast NASDAQ:BPTH

Price Target and Analyst Ratings

Most Recent Rating

HC Wainwright is very positive about BPTH and gave it a "Buy" rating on April 13, 2021. The price target was set to $12.00.

Last 30 Days

Historical Ratings

Date Rating Action Authority Current Price Target Price
2021-04-13 Buy Reiterated by HC Wainwright $6.66 $12.00
2021-04-06 Positive - Buy Reiterated by HC Wainwright $7.52 $10.00 → $12.00
2021-03-17 Buy Initiated by Roth Capital $6.86 $13.00
2021-03-11 Buy Initiated by Roth Capital $7.25 $13.00
2020-11-16 Buy Target Lowered by HC Wainwright $3.30 $12.00 → $10.00
2020-08-17 Buy Target Lowered by HC Wainwright $4.75 $18.00 → $12.00
2020-05-18 Buy Reiterated by HC Wainwright $5.35 $25.00 → $18.00

BPTH Stock Trend

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled.

Given the current short-term trend, the stock is expected to fall -21.10% during the next 3 months and, with a 90% probability hold a price between $3.67 and $4.68 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

Data

Date Bottom Mid Top
2021-09-30 $4.62 $5.27 $5.91
2021-10-01 $4.60 $5.24 $5.88
2021-10-04 $4.57 $5.22 $5.86
2021-10-05 $4.55 $5.19 $5.83
2021-10-06 $4.52 $5.17 $5.81
2021-10-07 $4.50 $5.14 $5.78
2021-10-08 $4.47 $5.12 $5.76
2021-10-11 $4.45 $5.09 $5.73
2021-10-12 $4.42 $5.07 $5.71
2021-10-13 $4.40 $5.04 $5.68
2021-10-14 $4.37 $5.02 $5.66
2021-10-15 $4.35 $4.99 $5.63
2021-10-18 $4.32 $4.96 $5.61
2021-10-19 $4.30 $4.94 $5.58
2021-10-20 $4.27 $4.91 $5.56
2021-10-21 $4.25 $4.89 $5.53
2021-10-22 $4.22 $4.86 $5.51
2021-10-25 $4.20 $4.84 $5.48
2021-10-26 $4.17 $4.81 $5.46
2021-10-27 $4.15 $4.79 $5.43
2021-10-28 $4.12 $4.76 $5.41
2021-10-29 $4.10 $4.74 $5.38
2021-11-01 $4.07 $4.71 $5.36
2021-11-02 $4.04 $4.69 $5.33
2021-11-03 $4.02 $4.66 $5.31
2021-11-04 $3.99 $4.64 $5.28
2021-11-05 $3.97 $4.61 $5.25
2021-11-08 $3.94 $4.59 $5.23
2021-11-09 $3.92 $4.56 $5.20
2021-11-10 $3.89 $4.54 $5.18

About Bio-Path Holdings

Bio-Path Holdings Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused antisense drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is Liposomal Grb2, which is in Phase II clinical trials for the t... Read more

Golden Star Signal

This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.

This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!

Get access to Golden Star list now!

StockInvest.usJoin 95.000+ Happy Subscribers

Don't miss out on the runners!

Get The StockInvest.Us Newsletter

StockInvest.usStock Podcast

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT